1-6 of 6
Patrick Urban
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Primary results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) who failed first-line corticosteroid treatment

Free
Hanny Al-Samkari, Adam Cuker, Francesco Zaja, Marc Michel, Waleed Ghanima, Thomas Stauch, Lei Zhang, Ming Hou, Thomas Zander, Azizan Sharif, Jing Sun, Prof. Uttam Kumar Nath, Roger Schutgens, Elena Rossi, Lien Deleu, Libor Červinek, Jae-Ho Yoon, Hung Chang, Theera Ruchutrakool, Masaki Iino, Tatsunori Goto, Patrick Urban, Justyna Fronczek, Matthew Foster, Marine Weill, Nicola Cooper
Journal: Blood
Blood (2025) 146 (Supplement 2): LBA-2.
https://doi.org/10.1182/blood-2025-LBA-2
Published: 2025
Journal Articles

Pre-treatment immune profiling by flow cytometry and single-cell transcriptomics identifies distinct features in B and T cells in rituximab responders and non-responders

Free
Alicia Au, Michelle MH Tan, Akhil Khera, Amna Malik, Nehal Joshi, Lucy Kamuriwo, Rocel Saputil, Spencer Mackie, Cynthia Lee, Camelia Vladescu, Bridget Chivers, Tung Le, Patrick Urban, Tiffany Loy, Andreas Bruederle, Nicola Cooper
Journal: Blood
Blood (2025) 146 (Supplement 1): 734.
https://doi.org/10.1182/blood-2025-734
Published: 2025
Journal Articles

Secondary analysis results from VAYHIT3, a phase 2 study of ianalumab in patients with primary immune thrombocytopenia previously treated with at least two lines of therapy

Free
Philip Choi, Charlotte Bradbury, Tomas Jose Gonzalez-Lopez, Muhlis Cem Ar, Karolin Trautmann-Grill, Mathias Rummel, Alessandra Borchiellini, Nicola Cooper, Fernando Chuliber, Rushad Patell, Blanca Sanchez, Patrick Urban, Alex Allepuz, Fabienne Le Gac, Renxin Lin, David Kuter
Journal: Blood
Blood (2025) 146 (Supplement 1): 844.
https://doi.org/10.1182/blood-2025-844
Published: 2025
Journal Articles

A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3

Free
David J Kuter, Tomas Jose Gonzalez Lopez, Karolin Trautmann-Grill, Mathias J. Rummel, Philip Young-Ill Choi, Alessandra Borchiellini, Muhlis Cem Ar, Huyen Tran, Tienan Zhu, Jae-Ho Yoon, Nichola Cooper, Thomas Stauch, Pinar Tarkun, Fabienne Le Gac, Alex Allepuz, Patrick Urban, Renxin Lin, Charlotte A. Bradbury
Journal: Blood
Blood (2024) 144 (Supplement 1): 710.
https://doi.org/10.1182/blood-2024-201418
Published: 2024
Journal Articles

Ianalumab, a Novel Anti-B-Cell Activating Factor (BAFF) Receptor (BAFF-R) Monoclonal Antibody (mAb) in Development for Immune Thrombocytopenia (ITP) and Warm Autoimmune Hemolytic Anemia (wAIHA), Has Demonstrated a Favorable Safety Profile in Sjögren's Syndrome (SjS), Systemic Lupus Erythematosus (SLE) and Chronic Lymphocytic Leukemia (CLL)

Free
Adam Cuker, Hanny Al-Samkari, Wilma Barcellini, Nichola Cooper, Waleed Ghanima, Marc Michel, Raymond SM Wong, Francesco Zaja, Fengkui Zhang, Patrick Urban, Roberto Abi Rached, David J Kuter
Journal: Blood
Blood (2023) 142 (Supplement 1): 5427.
https://doi.org/10.1182/blood-2023-180055
Published: 2023
Journal Articles

A Phase III Clinical Trial Program Investigating the Efficacy and Safety of Ianalumab in Patients with Primary Immune Thrombocytopenia (VAYHIT1 and VAYHIT2) and Warm Autoimmune Hemolytic Anemia (VAYHIA)

Free
Hanny Al-Samkari, Wilma Barcellini, Nichola Cooper, Waleed Ghanima, Marc Michel, Raymond SM Wong, Francesco Zaja, Fengkui Zhang, Patrick Urban, Alex Allepuz, Justyna Fronczek-Sokol, Jens Haenig, Pascal Edrich, Adam Cuker
Journal: Blood
Blood (2023) 142 (Supplement 1): 5456.
https://doi.org/10.1182/blood-2023-180647
Published: 2023